The Borrelia IgG immunoassay is a 2 hour, 96-well indirect ELISA for the qualitative or quantitative determination of Borrelia IgG antibodies in human serum, plasma and cerebrospinal fluid (CSF) samples. The Borrelia assay employs human serum-based standards to ensure the measurement of biologically reliable data.
The Borrelia test kit uses a recombinant antigen mix to improve the diagnostic specificity:
- p18: B. afzelii (pKo)
- p21 = OspC (outer surface protein C): B. burgdorferi s.s (B31), B. garinii (20047)
- p100: B. afzelii (pKo)
- VlsE: fusion proteins of different Borrelia genospecies